.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

CME Opportunities

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Refining Approaches to Reach Treatment Goals in mRCC

EP. 1: Introduction: Surgical Approaches in mRCC

March 26th 2015

EP. 2: Role of Radiation Therapy in Renal Cell Carcinoma

March 26th 2015

EP. 3: Managing Untreated Metastatic Renal Cell Carcinoma

March 26th 2015

EP. 4: Sunitinib Versus Pazopanib in Renal Cell Carcinoma

March 26th 2015

EP. 5: VEGF Versus mTOR in Non-Clear Cell RCC

March 26th 2015

EP. 6: Investigational Approaches in RCC

March 26th 2015

EP. 7: Second-Line Treatments in RCC

March 26th 2015

EP. 8: Second-Line Cabozantinib in mRCC

March 26th 2015

EP. 9: Immune Checkpoint Inhibition in RCC

March 26th 2015

EP. 10: Genetic Testing in RCC

March 26th 2015